Accessibility Menu
 
Smith & Nephew Plc logo

Smith & Nephew Plc

(NYSE) SNN

Current Price$31.69
Market Cap$13.41B
Since IPO (1999)+513%
5 Year-4%
1 Year+15%
1 Month-13%

Smith & Nephew Plc Financials at a Glance

Market Cap

$13.41B

Revenue (TTM)

$11.99B

Net Income (TTM)

$1.04B

EPS (TTM)

$1.44

P/E Ratio

21.86

Dividend

$0.78

Beta (Volatility)

0.70 (Low)

Price

$31.69

Volume

21,107

Open

$31.65

Previous Close

$31.59

Daily Range

$31.21 - $31.84

52-Week Range

$23.91 - $38.79

SNN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Smith & Nephew Plc

Industry

Healthcare Equipment and Supplies

Employees

18,362

CEO

Deepak S Nath, PhD

Headquarters

Watford, WD18 8YE, GB

SNN Financials

Key Financial Metrics (TTM)

Gross Margin

68%

Operating Margin

16%

Net Income Margin

10%

Return on Equity

12%

Return on Capital

12%

Return on Assets

6%

Earnings Yield

4.57%

Dividend Yield

0.02%

Payout Ratio

52.80%

Stock Overview

Market Cap

$13.41B

Shares Outstanding

424.50M

Volume

21.11K

Short Interest

0.00%

Avg. Volume

889.99K

Financials (TTM)

Gross Profit

$4.20B

Operating Income

$1.01B

EBITDA

$1.58B

Operating Cash Flow

$1.29B

Capital Expenditure

$434.01M

Free Cash Flow

$853.99M

Cash & ST Invst.

$557.00M

Total Debt

$3.33B

Smith & Nephew Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$3.19B

+13.3%

Gross Profit

$2.09B

+4.9%

Gross Margin

65.56%

N/A

Market Cap

$13.41B

N/A

Market Cap/Employee

$772.94K

N/A

Employees

17,349

N/A

Net Income

$330.82M

+263.5%

EBITDA

$856.21M

+57.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.77B

+0.4%

Accounts Receivable

$1.43B

+34.9%

Inventory

$2.12B

-11.6%

Long Term Debt

$3.18B

+37.0%

Short Term Debt

$150.00M

-80.4%

Return on Assets

6.10%

N/A

Return on Invested Capital

11.55%

N/A

Free Cash Flow

$594.67M

+153.1%

Operating Cash Flow

$888.43M

+79.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NBIXNeurocrine Biosciences, Inc.
$132.95+3.29%
MEDPMedpace Holdings, Inc.
$479.34+4.14%
FMSFresenius Medical Care AG & Co. KGaA
$22.39+0.83%
COOThe Cooper Companies, Inc.
$71.40+3.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.66-0.10%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$81.08-0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.22+0.10%
QQQInvesco QQQ Trust
$575.30+0.03%

Questions About SNN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.